Alira Health, an international healthcare and life sciences advisory services firm, announced that it has acquired Cros NT, a data-driven contract research organization headquartered in Italy with offices across Europe and the United States.
“The synergies among our regulatory, clinical and real-world evidence practices and Cros NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said Gabriele Brambilla, chief executive officer at Alira Health. “The addition of Cros NT will also enable Alira Health to expand our direct clinical operations in Europe. We embrace Cros NT’s commitment and passion to being a visionary in clinical research and are proud to welcome Cros NT CEO, Paolo Morelli, and his team to our fast-growing company.”
“We are excited to contribute to Alira Health’s mission of healthcare transformation, creating value for patients,” said Paolo Morelli, CEO of Cros NT. “Our experienced team of professionals will deliver value through our combined services, accelerating innovation and delivering tomorrow’s standard of care to patients.”
Morelli will join Alira Health’s leadership as executive vice president, biometrics, and will lead the growth of Alira Health’s data science services.